| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -170.24M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, FTH returned +290.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +191.0% |
| 1 year | +290.0% |
| 5 years | -85.6% |
| All-time high | $330.00 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in FTH would be worth today ›No. Faeth Therapeutics, Inc. has not paid a dividend in the past 12 months.
Faeth Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol FTH.
Faeth Therapeutics, Inc. is part of the Healthcare sector.
Faeth Therapeutics, Inc. has a market cap of 802.22M USD, based on the latest quote.
Faeth Therapeutics, Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
